Group One Trading
BEAM icon

Group One Trading’s Beam Therapeutics BEAM Stock Holding History

Group One Trading’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$112K Buy
4,700
+2,300
+96% +$63.8K ﹤0.01% 4625
2025
Q4 		$66.5K Sell
2,400
-6,900
-74% -$176K ﹤0.01% 5348
2025
Q3 		$226K Sell
9,300
-60,000
-87% -$1.19M ﹤0.01% 4555
2025
Q2 		$1.18M Buy
69,300
+46,200
+200% +$805K ﹤0.01% 2611
2025
Q1 		$451K Buy
23,100
+19,100
+478% +$500K ﹤0.01% 3200
2024
Q4 		$99.2K Sell
4,000
-14,100
-78% -$360K ﹤0.01% 4532
2024
Q3 		$443K Buy
18,100
+5,200
+40% +$134K ﹤0.01% 2937
2024
Q2 		$302K Sell
12,900
-3,700
-22% -$90.9K ﹤0.01% 3038
2024
Q1 		$548K Buy
16,600
+10,600
+177% +$330K ﹤0.01% 2640
2023
Q4 		$163K Buy
+6,000
New +$149K ﹤0.01% 4040
2023
Q3 		– Sell
-12,000
Closed -$383K – 7648
2023
Q2 		$383K Sell
12,000
-78,900
-87% -$2.56M ﹤0.01% 3287
2023
Q1 		$2.78M Buy
90,900
+12,100
+15% +$478K 0.01% 1259
2022
Q4 		$3.08M Buy
78,800
+75,600
+2,363% +$3.39M 0.01% 1472
2022
Q3 		$152K Sell
3,200
-19,900
-86% -$1.14M ﹤0.01% 4398
2022
Q2 		$894K Sell
23,100
-220,700
-91% -$8.77M ﹤0.01% 2863
2022
Q1 		$14M Buy
243,800
+225,200
+1,211% +$14.8M 0.01% 799
2021
Q4 		$1.48M Sell
18,600
-8,400
-31% -$719K ﹤0.01% 2930
2021
Q3 		$2.35M Sell
27,000
-4,800
-15% -$482K ﹤0.01% 2484
2021
Q2 		$4.09M Buy
31,800
+22,000
+224% +$1.75M ﹤0.01% 1891
2021
Q1 		$784K Sell
9,800
-200
-2% -$19K ﹤0.01% 3519
2020
Q4 		$816K Buy
+10,000
New +$492K ﹤0.01% 2824

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Group One Trading's BEAM Position: Q1 2026 in Review

Group One Trading reduced its Beam Therapeutics (BEAM) stake by 64% in Q1 2026, selling an estimated $159K and leaving 3,216 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4948.

Group One Trading first reported a position in BEAM in Q4 2020 and has held it in 12 quarters since. The position peaked at $5.32M in Q1 2022. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Group One Trading held 3,216 shares of Beam Therapeutics worth $76.6K as of Q1 2026.
  • Group One Trading sold 5,736 Beam Therapeutics shares in Q1 2026, an estimated $159K.
  • Beam Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4948 holding.
  • Group One Trading first reported a position in Beam Therapeutics in Q4 2020 and has held it in 12 quarters since.
  • Group One Trading's Beam Therapeutics position peaked at $5.32M in Q1 2022.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.